טוען...
Update on Targeted Therapies for Clear Cell Renal Cell Carcinoma
VEGF and mTOR-targeted therapies continue to play a critical role in the management of advanced and metastatic RCC. Ongoing research to identify novel agents continues to build upon the work done during the elucidation of the VHL/clear cell RCC pathway. It is hoped that ongoing and planned studies w...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3488422/ https://ncbi.nlm.nih.gov/pubmed/21330923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e32834479c0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|